BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 12394635)

  • 21. Strategies for the diagnosis of mitochondrial fatty acid beta-oxidation disorders.
    Sim KG; Hammond J; Wilcken B
    Clin Chim Acta; 2002 Sep; 323(1-2):37-58. PubMed ID: 12135806
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New genetic defects in mitochondrial fatty acid oxidation and carnitine deficiency.
    Stanley CA
    Adv Pediatr; 1987; 34():59-88. PubMed ID: 3318304
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic disorders of carnitine metabolism and their nutritional management.
    Kerner J; Hoppel C
    Annu Rev Nutr; 1998; 18():179-206. PubMed ID: 9706223
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An introduction to nutritional treatment in inborn errors of metabolism--different disorders, different approaches.
    Wilcken B
    Southeast Asian J Trop Med Public Health; 2003; 34 Suppl 3():198-201. PubMed ID: 15906735
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Mitochondrial beta-oxidation defects: overview].
    Yamaguchi S
    Ryoikibetsu Shokogun Shirizu; 2001; (36):60-4. PubMed ID: 11596451
    [No Abstract]   [Full Text] [Related]  

  • 26. Fatty Acid oxidation defects.
    Goh DL
    Ann Acad Med Singap; 2008 Dec; 37(12 Suppl):74-3. PubMed ID: 19904457
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Selective Screening of Fatty Acids Oxidation Defects and Organic Acidemias by Liquid Chromatography/tandem Mass Spectrometry Acylcarnitine Analysis in Brazilian Patients.
    Vargas CR; Ribas GS; da Silva JM; Sitta A; Deon M; de Moura Coelho D; Wajner M
    Arch Med Res; 2018 Apr; 49(3):205-212. PubMed ID: 30119976
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fatty acid oxidation in peripheral blood cells: characterization and use for the diagnosis of defects of fatty acid oxidation.
    Schaefer J; Pourfarzam M; Bartlett K; Jackson S; Turnbull DM
    Pediatr Res; 1995 Mar; 37(3):354-60. PubMed ID: 7784145
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Defects in mitochondrial fatty acid oxidation: clinical presentations and their role in sudden infant death.
    Pollitt RJ
    Padiatr Padol; 1993; 28(1):13-7. PubMed ID: 8446423
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inborn defects of fatty acid oxidation: a preventable cause of SIDS.
    Keppen LD; Randall B
    S D J Med; 1999 Jun; 52(6):187-8; disscussion 188-9. PubMed ID: 10388343
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fifty years of research on mitochondrial fatty acid oxidation disorders: The remaining challenges.
    Vianey-Saban C; Guffon N; Fouilhoux A; Acquaviva C
    J Inherit Metab Dis; 2023 Sep; 46(5):848-873. PubMed ID: 37530674
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Very long chain acyl-CoA dehydrogenase deficiency: identification of a new inborn error of mitochondrial fatty acid oxidation in fibroblasts.
    Bertrand C; Largillière C; Zabot MT; Mathieu M; Vianey-Saban C
    Biochim Biophys Acta; 1993 Jan; 1180(3):327-9. PubMed ID: 8422439
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nutritional management of infants with inborn metabolic errors.
    Morrow G
    Clin Perinatol; 1975 Sep; 2(2):361-72. PubMed ID: 1102228
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long chain fatty acid oxidation defects in children: importance of detection and treatment options.
    Hayes B; Lynch B; O'Keefe M; Monavari AA; Treacy EP
    Ir J Med Sci; 2007 Sep; 176(3):189-92. PubMed ID: 17431731
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of fatty acid oxidation intermediates in cultured fibroblasts to detect mitochondrial oxidation disorders.
    Pourfarzam M; Schaefer J; Turnbull DM; Bartlett K
    Clin Chem; 1994 Dec; 40(12):2267-75. PubMed ID: 7988014
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Complications in early diagnosis and treatment of two infants with long-chain fatty acid beta-oxidation defects.
    Skladal D; Sass JO; Geiger H; Geiger R; Mann C; Vreken P; Wanders RJ; Trawöger R
    J Pediatr Gastroenterol Nutr; 2000 Oct; 31(4):448-52. PubMed ID: 11045847
    [No Abstract]   [Full Text] [Related]  

  • 37. Molecular basis of mitochondrial fatty acid oxidation defects.
    Coates PM; Tanaka K
    J Lipid Res; 1992 Aug; 33(8):1099-110. PubMed ID: 1431593
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [INBORN ERRORS OF FATTY ACID METABOLISM (REVIEW)].
    Zharmakhanova G; Syrlybayeva L; Nurbaulina E; Baikadamova L; Eshtayeva G
    Georgian Med News; 2020 Jun; (303):161-167. PubMed ID: 32841199
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of carnitine and fatty acid oxidation and its defects in infantile epilepsy.
    Tein I
    J Child Neurol; 2002 Dec; 17 Suppl 3():3S57-82; discussion 3S82-3. PubMed ID: 12597056
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inherited disorders of mitochondrial fatty acid oxidation.
    Coates PM; Stanley CA
    Prog Liver Dis; 1992; 10():123-38. PubMed ID: 1296227
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.